Vismodegib



Indications and Reactions:

Role Indications Reactions
Primary
Basal Cell Carcinoma 28.9%
Product Used For Unknown Indication 10.7%
Hypertension 10.0%
Prophylaxis 5.1%
Constipation 4.2%
Pain 4.0%
Diabetes Mellitus 3.8%
Pancreatic Carcinoma Metastatic 3.6%
Nausea 3.3%
Depression 3.1%
Hypothyroidism 2.9%
Head And Neck Cancer 2.7%
Pancreatic Carcinoma 2.7%
Small Cell Lung Cancer 2.7%
Neoplasm Malignant 2.4%
Chondrosarcoma 2.2%
Anaemia 2.0%
Muscle Spasms 2.0%
Small Cell Lung Cancer Stage Unspecified 2.0%
Hypersensitivity 1.8%
Gamma-glutamyltransferase Increased 8.9%
Hepatitis 8.0%
Hepatotoxicity 6.3%
Thrombosis 6.3%
Death 5.4%
Hepatic Enzyme Increased 5.4%
Hyponatraemia 5.4%
Infection 5.4%
Syncope 5.4%
Alanine Aminotransferase Increased 4.5%
Angioedema 4.5%
Aspartate Aminotransferase Increased 4.5%
Disease Progression 4.5%
Hypoglycaemia 4.5%
Weight Decreased 4.5%
Cerebrovascular Accident 3.6%
Cytolytic Hepatitis 3.6%
Loss Of Consciousness 3.6%
Pyrexia 3.6%
Anaemia 2.7%
Secondary
Basal Cell Carcinoma 20.8%
Product Used For Unknown Indication 18.8%
Adenocarcinoma Pancreas 9.7%
Metastatic Malignant Melanoma 6.3%
Small Cell Lung Cancer Extensive Stage 4.2%
Small Cell Lung Cancer Stage Unspecified 4.2%
Depression 3.5%
Hypothyroidism 3.5%
Medulloblastoma 3.5%
Chondrosarcoma 2.8%
Gastric Cancer 2.8%
Gastrooesophageal Cancer 2.8%
Headache 2.8%
Anxiety 2.1%
Dyspepsia 2.1%
Enuresis 2.1%
Epilepsy 2.1%
Hypocholesterolaemia 2.1%
Inflammation 2.1%
Nausea 2.1%
Weight Decreased 13.0%
Hepatotoxicity 10.9%
Infection 10.9%
Alanine Aminotransferase Increased 6.5%
Angioedema 6.5%
Aspartate Aminotransferase Increased 6.5%
Gamma-glutamyltransferase Increased 6.5%
Death 4.3%
Insomnia 4.3%
Localised Infection 4.3%
Perinephric Abscess 4.3%
Pulmonary Embolism 4.3%
Atrial Fibrillation 2.2%
Back Pain 2.2%
Cerebrovascular Accident 2.2%
Hepatic Enzyme Increased 2.2%
Incisional Hernia 2.2%
Incorrect Dose Administered 2.2%
Lung Neoplasm Malignant 2.2%
Meningitis Aseptic 2.2%
Concomitant
Hysterectomy 33.3%
Hypertension 22.2%
Basal Cell Carcinoma 11.1%
Dry Skin 11.1%
Hyperthyroidism 11.1%
Thrombosis 11.1%
Knee Operation 100.0%